One of the most common decisions in immune cell research is whether to use fresh or cryopreserved cells.
Both play a critical role, and the choice depends on the balance between biological sensitivity and operational reality.
Fresh cells are often preferred for:
💦 highly sensitive functional assays
💦 immediate activation or response studies
💦 workflows requiring minimal manipulation
Cryopreserved cells enable:
🧊 long-term storage and flexible scheduling
🧊 global distribution and multi-site studies
🧊 consistent, repeatable experiments using matched donor lots
🧊 scalability for regulated and clinical workflows
Today, many advanced research and clinical programs rely on cryopreserved cells to ensure reproducibility, comparability, and operational control. While fresh cells remain essential when maximal native function is required.
Choosing the right format is not about preference, it’s about aligning the biology with the demands of the study.
